Patient-Friendly Explanation

Immunosuppressants are medicines that calm the immune system so that a transplanted organ is not rejected. Many people who take them, especially together with steroid tablets, gain weight: partly because appetite increases and fluid is retained, and partly because the medicines change how the body handles sugar and fat.

Clinical Definition

Immunosuppressive regimens commonly combine a calcineurin inhibitor (tacrolimus or ciclosporin) with an antimetabolite such as mycophenolate or azathioprine, and often corticosteroids. Weight gain is driven by corticosteroid-induced appetite and central fat deposition, calcineurin inhibitor-associated glucose intolerance, hypertension and fluid retention, together with reduced physical activity after transplant.

Why It Matters

Weight gain of 5 to 10 per cent in the first year after transplant is common and raises cardiovascular and graft risk. Because the regimen cannot simply be stopped, management focuses on appetite-aware nutrition, resistance training and tighter glycaemic control, planned together with the transplant team. NuLifeCare Singapore coordinates weight care for patients on long-term immunosuppression rather than treating the medicines as the only problem.